Dancann Pharma A/S
A/SBankruptAdvertising protectionCVR 39426005Rugvænget 5, 6823 AnsagerManufacture of pharmaceutical preparations· NACE 2120Est. 2018 · 8 years old1 employeeshttps://dancann.com
Loading company…
Overview
Dancann Pharma A/S is a Danish A/S based in Ansager, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2018, the company has 1 employee and reported revenue of DKK 0 in its latest annual filing.
Revenue 2024
0M DKK
EBITDA margin
—
Net profit 2024
-8.3M DKK
+87% vs 2023
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2024), Dancann Pharma A/S reported revenue of DKK 0. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net loss of DKK 8.3m.
At the end of 2024, equity financed 91.5% of the balance sheet, and current assets covered short-term debt 1.9 times.
Financials
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
People & ownership
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
JEQ Capital AB
Dancann Pharma A/S